The Simultaneous Measurement of Plasma-Aldosterone- and -Renin-Concentration Allows Rapid Classification of all Disorders of the Renin-Aldosterone System

Abstract

Objective: The determination of the plasma aldosterone (PAC) to the plasma renin concentration (PRC) ratio is an accepted screening tool for primary hyperaldosteronism (PHyperA).

Design: To assess the diagnostic significance of this ratio for other disorders of the renin-aldosterone-system (RAS), we examined 60 patients with different adrenal diseases, 32 patients with essential hypertension and 76 normotensive healthy volunteers. The aldosterone (pmol/L) and renin (mU/L) concentrations were measured in one plasma sample by an automated chemiluminescence assay (Nichols Advantage^®).

Results: Patients with PHyperA (n=31) had a PAC/PRC ratio between 105 and 2328 and could be distinguished without overlap from the essential hypertension group (ratio: range 2.7-49) and normal healthy volunteers (ratio: range 0.9-71). Fourteen patients with primary hypoaldosteronism showed low PAC/PRC ratios (range 0.21-0.98) and low PAC values (range: 42-100). Seven patients with secondary hypoaldosteronism had normal PAC/PRC ratios (range 2.8-23.2) and low PAC values (range: 42-116). Eight patients with secondary hyperaldosteronism had normal PAC/PRC ratios (range 7.8-67.9) and elevated PAC values (range: 803-2917). The graphic presentation of these data allowed the differentiation of all major disorders of the RAS.

Conclusions: The measurement of PAC/PRC ratios using this automated system provides a sensitive and rapid screening method for PHyperA. Moreover, the measurement of both the PAC and the PAC/PRC ratio allows differentiation of other disorders of the RAS.

Plasma renin concentration - plasma aldosterone concentration - renin-angiotensin-aldosterone system - automated chemiluminescence assays

References

• 1 Bruin RA, Bouhuizen A, Diederich S, Perschel FH, Boomsma F, Deinum J. Validation of a new rapid renin assay.  Clin Chem. 2004;  50 2111-2116
• 2 Fardella CE, Mosso L, Gomez-Sanchez C, Cortes P, Soto J, Gomez L, Pinto M, Huete A, Oestreicher E, Foradori A, Monteri J. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.  J Clin Endocrinol Metab. 2000;  85 1863-1867
• 3 Ferrari P, Shaw SG, Nicod J, Saner E, Nussberger J. Active renin versus plasma renin activity to define aldosterone-to-renin ratio for primary aldosteronism.  J Hypertens. 2004;  22 377-381
• 4 Funder JW. Aldosterone-Renin ratios in the context of primary care.  J Clin Endocrinol Metab. 2004;  89 4219-4220
• 5 Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC. Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio.  Am J Kidney Dis. 2001;  37 699-705
• 6 Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension.  Clin Exp Pharmacol Physiol. 1994;  21 315-318
• 7 Hartman D, Sagnella GA, Chesters CA, MacGregor GA. Direct Renin Assay and Plasma Renin Activity Assay Compared.  Clin Chem. 2004;  50 2159-2161
• 8 Lamarre-Cliche M, Champlain J, Lacourciere Y, Poirier L, Karas M, Larochelle P. Effects of circdian rhythms, posture, and medication on renin-aldosterone interrelations in essential hypertensives.  Am J Hypertens. 2005;  18 56-64
• 9 MacKenna TJ, Sequeira SJ, Heffernan A, Chambers J, Cunningham S. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism.  J Clin Endocrinol Metab. 1991;  73 952-957
• 10 Morganti A, Pelizzola D, Mantero F, Gazzano G, Opocher G, Piffanelli A. Immunoradiometric versus enzymatic renin assay: results of the Italian Multicenter Comparative Study. Italian Multicenter Study for Stan-dardization of Renin Measurement.  J Hypertens. 1995;  13 19-26
• 11 Mulatero P, Rabbio F, Milan A, Paglieri C, Morello F, Chiandussi L, Veglio F. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.  Hypertension. 2002;  40 897-902
• 12 Oelkers W, Diederich S, Bähr V. Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone.  J Clin Endocrinol Metab. 1992;  75 259-264
• 13 Olivieri O, Ciacciarelli A, Signorelli D, Pizzolo F, Guarini P, Pavan C, Corgnati A, Falcone S, Corrocher R, Micchi A, Cressoni C, Blengio G. Aldosterone to Renin ratio in a primary care setting: the bussolengo study.  J Clin Endocrinol Metab. 2004;  89 4221-4226
• 14 Perschel FH, Schemer R, Seiler L, Reincke M, Deinum J, Maser-Gluth C, Mechelhoff D, Tauber R, Diederich S. Rapid Screening Test for Primary Hyperaldosteronism: Ratio of Plasma Aldosterone to Renin Concentration Determined by Fully Automated Chemiluminescence Immunoassays.  Clin Chem. 2004;  50 1650-1655
• 15 Quinkler M, Lepenies J, Diederich S. Primary hyperaldosteronism.  Exp Clin Endocrinol Diabetes. 2002;  110 263-271
• 16 Schirpenbach C, Seiler L, Maser-Gluth C, Beuschlein F, Reincke M, Bidlingmaier M. Automated chemiluminoscence-immunoassay for aldosterone during dynamic testing: comparison to radioimmunoassays with and without extraction steps.  Clin Chem. 2006;  52 1749-1755
• 17 Seifarth C, Trenkel S, Schobel H, Hahn EG, Hensen J. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.  Clin Endocrinol (Oxf). 2002;  57 457-465
• 18 Stowasser M, Gordon RD. Primary aldosteronism - careful investigation is essential and rewarding.  Mol Cell Endocrinol. 2004;  217 33-39
• 19 Stowasser M, Gordon RD. Aldosterone assays: an urgent need for improvement.  Clin Chem. 2006;  52 1640-1642
• 20 Trenkel S, Seifarth C, Schobel H, Hahn EG, Hensen J. Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism.  Exp Clin Endocrinol Diabetes. 2002;  110 80-85
• 21 Unger N, Lopez Schmidt I, Pitt C, Walz MK, Philipp T, Mann K, Petersenn S. Comparison of active renin concentration and plasma renin activity for the diagnosis of primary hyperaldosteronism in patients with an adrenal mass.  Eur J Endocrinol. 2004;  150 517-523
• 22 WHO . Reducing Risks, Promoting Healthy Life.  The World Health Report. 2002;  58
• 23 Young  WF. Minireview: primary aldosteronism - changing concepts in diagnosis and treatment.  Endocrinology. 2003;  144 2208-2213

Correspondence